Ex vivo glioblastoma migration phenotypes define clinical recurrence and tumor heterogeneity
The utility of ex vivo glioblastoma characterization is demonstrated, allowing decoding of tumor heterogeneity and clinical prognostication as well as providing a framework for deconvoluting the complex cancer phenotype.